The impact of comorbidity on the survival of patients with laryngeal squamous cell carcinoma

Acta Oto-Laryngologica

Volumn 131, Issue 8, 2011, Pages 840-846

  Gimeno Hernández, Jesus ^a,b   Iglesias Moreno, Mari Cruz ^a,b   Gómez Serrano, Manuel ^a,b   Carricondo, Francisco ^b   Gil Loyzaga, Pablo ^b   Poch Broto, Joaquin ^a,b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cancer; Charlson index; Larynx; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CAUSE OF DEATH; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEMILARYNGECTOMY; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RETROSPECTIVE STUDY; SPINDLE CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; TOTAL PHARYNGOLARYNGECTOMY; ULCER; VERRUCOUS CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL RATE; TIME FACTORS;

EID: 79960446454     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.3109/00016489.2011.564651     Document Type: Article

References (20)

1. Piccirillo JF. Importance of comorbidity in head and neck cancer. Laryngoscope 2000;110:593-602. (Pubitemid 30198711)
2. Hall SF. A users guide to selecting a comorbidity index for clinical research. J Clin Epidemiol 2006;59:849-55. (Pubitemid 43975721)
3. Piccirillo JF, Vlahiotis MS. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis. Curr Oncol Rep 2006;8:123-9.
4. Castro MA, Dedivitis RA, Ribeiro KC. Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007;69:146-52. (Pubitemid 46597289)
5. Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-103. (Pubitemid 41103722)
6. Sabin SL, Rosenfeld RM, Sundaram K, Har-El G, Lucente FE. The impact of comorbidity and age on survival with laryngeal cancer. Ear Nose Throat J 1999;78: 578-84. (Pubitemid 29404356)
7. Chen AY, Matson LK, Roberts D, Goepfert H. The significance of comorbidity in advanced laryngeal cancer. Head Neck 2001;23:566-72. (Pubitemid 32565530)
8. Paleri V, Wight RG, Davies GR. Impact of comorbidity on the outcome of laryngeal squamous cancer. Head Neck 2003; 25:1019-26. (Pubitemid 37475264)
9. Castro MA, Dedivitis RA, Ribeiro KC. Comorbidity measurement in patients with laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2007;69:146-52. (Pubitemid 46597289)
10. Hall SF, Groome PA, Rothwell D. The impact of comorbidity on survival in patients with squamous cell carcinoma of the head and neck. Head Neck 2000;22:317-22. (Pubitemid 30413294)
11. Hall SF, Rochon PA, Streiner DL, Paszat LF, Groom PA, Rohland SL. Measuring comorbidity in patients with head and neck cancer. Laryngoscope 2002;112:1988-96. (Pubitemid 35283461)
12. Singh B, Bhaya M, Stern J, Roland J. Validation of the Charlson comorbidity index in patients with head and neck cancer. Laryngoscope 1997;107:1469-74.
13. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005;131:27-32. (Pubitemid 40105457)
14. Charlson ME, Pompei P, Ales K, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40: 373-83. (Pubitemid 17055592)
15. Charlson M., Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994;47: 1245-51. (Pubitemid 24361532)
16. Burke HB, Henson DE. The American Joint Committee on Cancer: criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-5. (Pubitemid 23335063)
17. Birim O, Maat AP, Kappetein AP, van Meerbeeck JP, Damhuis RA, Bogers AJ. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg 2003;23:30-4. (Pubitemid 35472093)
18. Piccirillo JF, Spitznagel EL, Vermani N, Costas I, Schnitzler M. Comparison of comorbidity indices for patients with head and neck cancer. Med Care 2004;42: 482-6.
19. Read WL, Tierney RM, Page NC, Costas I, Govindan R, Spitznagel EL, et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-103. (Pubitemid 41103722)
20. Alho OP, Hannula K, Luokkala A, Teppo H, Koivunen P, Kantola S. Differential prognostic impact of comorbidity in head and neck cancer. Head Neck 2007;29:913-18.